Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Berberine inhibits non‐small cell lung cancer cell growth through repressing DNA repair and replication rather than through apoptosis
Lulu Ni, Zhongjie Li, Hong‐Li Ren, et al.
Clinical and Experimental Pharmacology and Physiology (2021) Vol. 49, Iss. 1, pp. 134-144
Closed Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

Anticancer Effects and Mechanisms of Berberine from Medicinal Herbs: An Update Review
Ruo-Gu Xiong, Siyu Huang, Si-Xia Wu, et al.
Molecules (2022) Vol. 27, Iss. 14, pp. 4523-4523
Open Access | Times Cited: 88
Long non-coding RNAs and exosomal lncRNAs: Potential functions in lung cancer progression, drug resistance and tumor microenvironment remodeling
Maliheh Entezari, Maryam Ghanbarirad, Afshin Taheriazam, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 150, pp. 112963-112963
Open Access | Times Cited: 81
Berberine: An Important Emphasis on Its Anticancer Effects through Modulation of Various Cell Signaling Pathways
Saleh A. Almatroodi, Mohammed A. Alsahli, Arshad Husain Rahmani
Molecules (2022) Vol. 27, Iss. 18, pp. 5889-5889
Open Access | Times Cited: 57
Transforming growth factor-beta (TGF-β) in prostate cancer: A dual function mediator?
Sepideh Mirzaei, Mahshid Deldar Abad Paskeh, Yalda Saghari, et al.
International Journal of Biological Macromolecules (2022) Vol. 206, pp. 435-452
Closed Access | Times Cited: 44
Berberine diminishes the malignant progression of non-small cell lung cancer cells by targeting CDCA5 and CCNA2
Xin Zhao, HA Min-wen, Lulu Zhou, et al.
Journal of Natural Medicines (2025)
Closed Access | Times Cited: 1
Evaluation of the Cytotoxic Activity and Anti-Migratory Effect of Berberine–Phytantriol Liquid Crystalline Nanoparticle Formulation on Non-Small-Cell Lung Cancer In Vitro
Abdullah M. Alnuqaydan, Abdulmajeed G. Almutary, Mohd Azam, et al.
Pharmaceutics (2022) Vol. 14, Iss. 6, pp. 1119-1119
Open Access | Times Cited: 35
Phytantriol-Based Berberine-Loaded Liquid Crystalline Nanoparticles Attenuate Inflammation and Oxidative Stress in Lipopolysaccharide-Induced RAW264.7 Macrophages
Abdullah M. Alnuqaydan, Abdulmajeed G. Almutary, Mohd Azam, et al.
Nanomaterials (2022) Vol. 12, Iss. 23, pp. 4312-4312
Open Access | Times Cited: 29
Current understanding and future prospects on Berberine for anticancer therapy
Anjana Goel
Chemical Biology & Drug Design (2023) Vol. 102, Iss. 1, pp. 177-200
Closed Access | Times Cited: 22
Research progress of traditional Chinese medicine as sensitizer in reversing chemoresistance of colorectal cancer
Xiang Lin, Xinyu Yang, Yu‐Shang Yang, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 17
Berberine targets KIF20A and CCNE2 to inhibit the progression of nonsmall cell lung cancer via the PI3K/AKT pathway
Qi Wang, Hua Wu, Qingquan Wu, et al.
Drug Development Research (2023) Vol. 84, Iss. 5, pp. 907-921
Closed Access | Times Cited: 17
Berberine nanostructures attenuate ß-catenin, a key component of epithelial mesenchymal transition in lung adenocarcinoma
Vamshikrishna Malyla, Gabriele De Rubis, Keshav Raj Paudel, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2023) Vol. 396, Iss. 12, pp. 3595-3603
Open Access | Times Cited: 17
Unlocking the potential of Berberine: Advancing cancer therapy through chemosensitization and combination treatments
Anjana Sajeev, Bethsebie Sailo, Jyothsna Unnikrishnan, et al.
Cancer Letters (2024) Vol. 597, pp. 217019-217019
Closed Access | Times Cited: 6
Multi-Target Potential of Berberine as an Antineoplastic and Antimetastatic Agent: A Special Focus on Lung Cancer Treatment
Ijeoma Theresa Achi, Paromita Sarbadhikary, Blassan P. George, et al.
Cells (2022) Vol. 11, Iss. 21, pp. 3433-3433
Open Access | Times Cited: 27
Cancer Pathways Targeted by Berberine: Role of microRNAs
Mansoor Ali, Deepali Mishra, Rana P. Singh
Current Medicinal Chemistry (2024) Vol. 31, Iss. 32, pp. 5178-5198
Closed Access | Times Cited: 5
Berberine and berberine nanoformulations in cancer therapy: Focusing on lung cancer
Chou‐Yi Hsu, Harikumar Pallathadka, Jitendra Gupta, et al.
Phytotherapy Research (2024) Vol. 38, Iss. 8, pp. 4336-4350
Closed Access | Times Cited: 5
Therapeutic Application of Berberine: a Consolidated Review
Techi Mana, Oinam Bidyalaxmi Devi, Yengkhom Disco Singh
Current Pharmacology Reports (2023) Vol. 9, Iss. 5, pp. 329-340
Closed Access | Times Cited: 11
Berberine restrains non-small cell lung cancer cell growth, invasion and glycolysis via inactivating the SPC25/NUF2 pathway
Meng Lv, Xiangrui Chen, Qinbo Yang, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
Berberine inhibits metastasis of ovarian cancer by blocking lipid metabolism, alleviating aging of adipose tissue and increasing tumor infiltrating immune cells
Xiaojie Zhang, Bing Xiong, Yujie Cheng, et al.
Translational Oncology (2025) Vol. 56, pp. 102380-102380
Closed Access
A Systematic Review of Progress toward Unlocking the Power of Epigenetics in NSCLC: Latest Updates and Perspectives
Anetta Sulewska, Lothar R. Pilz, Christian Manegold, et al.
Cells (2023) Vol. 12, Iss. 6, pp. 905-905
Open Access | Times Cited: 8
Pharmacological Potential of Three Berberine-Containing Plant Extracts Obtained from Berberis vulgaris L., Mahonia aquifolium (Pursh) Nutt., and Phellodendron amurense Rupr
Alexandra Ciorîță, Sabina-Emanuela Erhan, Maria-Loredana Soran, et al.
Biomedicines (2024) Vol. 12, Iss. 6, pp. 1339-1339
Open Access | Times Cited: 3
Berberine Inhibits Dengue Virus through Dual Mechanisms
Thippayawan Ratanakomol, Sittiruk Roytrakul, Nitwara Wikan, et al.
Molecules (2021) Vol. 26, Iss. 18, pp. 5501-5501
Open Access | Times Cited: 19
Berberine inhibited the formation of metastasis by intervening the secondary homing of colorectal cancer cells in the blood circulation to the lung and liver through HEY2
Lulu Ni, Ping Sun, Min Ai, et al.
Phytomedicine (2022) Vol. 104, pp. 154303-154303
Closed Access | Times Cited: 14
Nanocarrier mediated co-delivery of phytochemicals and chemo-drugs: an emerging strategy to combat lung cancer in a systemic way
Priyanka Upadhyay, Avijit Ghosh, Vijaya Sarangthem, et al.
Phytochemistry Reviews (2023) Vol. 23, Iss. 2, pp. 485-527
Closed Access | Times Cited: 7
The convergence of in silico approach and nanomedicine for efficient cancer treatment; in vitro investigations on curcumin loaded multifunctional graphene oxide nanocomposite structure
Fatemeh Paknia, Hassan Mohabatkar, Meysam Ahmadi‐Zeidabadi, et al.
Journal of Drug Delivery Science and Technology (2022) Vol. 71, pp. 103302-103302
Closed Access | Times Cited: 10
Berberine Synergizes with Cisplatin via Inducing Apoptosis on A549 non-Small Cell Lung Cancer Cells
Merve Becit-Kızılkaya, Şeyma Öncü, Serkan Şen, et al.
European Journal of Therapeutics (2023) Vol. 29, Iss. 3, pp. 480-488
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top